Volume 16, Issue 1 (2012)
CLR 2012, 16(1): 47-79 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khademi H, Temmerman M. Establishment of National Patent Regime on Biotechnology. CLR 2012; 16 (1) :47-79
URL: http://clr.modares.ac.ir/article-20-2022-en.html
URL: http://clr.modares.ac.ir/article-20-2022-en.html
1- 1. Ph.D. Candidate in Law, University of Bern, Bern, Switzerland
2- 1. Ph.D. Candidate in Law, University of Bern, Bern, Switzerland 2. Ph.D. in Law, University of Bern, Bern, Switzerland
2- 1. Ph.D. Candidate in Law, University of Bern, Bern, Switzerland 2. Ph.D. in Law, University of Bern, Bern, Switzerland
Abstract: (5190 Views)
In 2007, the Iranian parliament decided to exclude genetic resources, genetic materials and biological processes for their production from the Iranian industrial property regime by adding article 4 (d) to the Patent, Industrial Designs and Trademarks Act. During the ratification, this rule caused controversial debates between proponents and opponents of protecting biotechnology inventions. Proponents of article 4 (d) considered the best choice to wait and see before taking a final decision. This was a wise choice in this context to review the literatures and different national, regional and international approaches on the issues of the patentability of genetic materials and biotechnology inventions enabled Iran to be aware of its specific needs and obligations on the subject; and to create a defensive protection regime of genetic resources.
In contrast, opponents of article 4 (d) emphasize that the importance of biotechnology does not decrease and that more than enough information is available today to take an informed decision and tailor an adequate patent law applicable in this field. Concerning such a challenge, this paper analyzes the main approaches of the patent regimes with the goal of establishing a balanced regime on protection of biotech inventions as well as protection of genetic resources.
.
Received: 2012/05/7 | Accepted: 2012/06/20 | Published: 2012/06/20
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |